MD Medical Group Recognized for Excellence in Investor Relations
MD Medical Group Investments Plc ("MDMG" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, received strong recognition at the Annual IR Magazine Awards Ceremony in Moscow.
MDMG was voted number one in the categories of Best IRO (small cap) and Grand Prix for Best Overall IR (small cap). In addition, the company came second place in the categories Best IR by the CEO (Elena Mladova) and Best IR by the CFO (Vitaly Ustimenko).
The IR Magazine award ceremony is one of the highest profile and most authoritative award ceremonies dedicated to the Russian IR community. The awards are based on an independent survey carried out by Thomson Reuters Extel among analysts, investors and other market participants.
Commenting on the awards, MDMG’s Head of IR Maxim Novikov said:
“It is a pleasure to work in a company where the senior leadership team is so committed to maintaining high-quality investor relations. I am proud of how much we have achieved as a team since we went public less than one year ago, and am delighted that our efforts were recognised so strongly by IR Magazine and the wider IR community. At the same time, we realise there is always scope for perfection, and Best Practice IR is a continually evolving concept. Going forward, we will continue to seek new ways to follow, or even define, best practice in investor relations.”
* * *
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012